Michael Mussallem, chairman and CEO of Edwards Lifesciences, knows what lies at the heart of innovation.
After all, his company is the world's number-one heart valve company and a global leader in products and technologies to treat advanced cardiovascular disease.
"One of the most important things we can do to drive medical innovation is apply advanced technology to address unmet patient needs," Mussallem says.
The Edwards Lifesciences Fund made a $5 million gift to The Henry Samueli School of Engineering to establish a center focused on researching and developing the next generation of cardiovascular devices. The Edwards Lifesciences Center for Advanced Cardiovascular Technology at UC Irvine will support interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The center will also provide a training environment for hosting prominent experts in the field of cardiovascular technology.
"We are proud to partner with a neighbor that is as accomplished and committed to excellence as UC Irvine to establish a center devoted to transformational cardiovascular technology research," Mussallem adds.
Mussallem's connections to UC Irvine extend beyond Edwards. He is vice chair of the Chief Executive Roundtable and member of the Engineering Advisory Board of The Henry Samueli School of Engineering.